PubRank

Larry C Lands

Author PubWeight™ 40.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2010 2.75
2 The relationship between single-breath diffusion capacity of the lung for nitric oxide and carbon monoxide during various exercise intensities. Chest 2004 2.23
3 Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis. Thorax 2013 2.20
4 Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. Pediatr Pulmonol 2012 2.08
5 Statement on Exercise Testing in Cystic Fibrosis. Respiration 2015 1.93
6 Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics 2008 1.72
7 Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis. Eur Respir J 2013 1.53
8 Ibuprofen modulates NF-kB activity but not IL-8 production in cystic fibrosis respiratory epithelial cells. Respiration 2009 1.46
9 Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. Am J Respir Cell Mol Biol 2007 1.09
10 Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosis. Pediatr Pulmonol 2008 1.04
11 Perioperative Steroids in Pediatric Cardiopulmonary Bypass: We Still Do Not Have All the Answers. Pediatr Crit Care Med 2016 1.01
12 Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country. Pediatrics 2006 0.99
13 Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa. Chest 2012 0.95
14 Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros 2003 0.91
15 High hydrostatic pressure enhances whey protein digestibility to generate whey peptides that improve glutathione status in CFTR-deficient lung epithelial cells. Mol Nutr Food Res 2006 0.91
16 Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms. J Biol Chem 2011 0.91
17 New therapies, new concerns: rituximab-associated lung injury. Pediatr Nephrol 2010 0.90
18 An open-label dose-response study of lymphocyte glutathione levels in healthy men and women receiving pressurized whey protein isolate supplements. Int J Food Sci Nutr 2007 0.89
19 Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-treatment with fenretinide. Int Immunopharmacol 2006 0.88
20 High hydrostatic pressure pre-treatment of whey proteins enhances whey protein hydrolysate inhibition of oxidative stress and IL-8 secretion in intestinal epithelial cells. Food Nutr Res 2012 0.85
21 Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: a randomized, controlled, double-blind pilot study. J Med Food 2010 0.85
22 Role of heme oxygenases in sepsis-induced diaphragmatic contractile dysfunction and oxidative stress. Am J Physiol Lung Cell Mol Physiol 2002 0.85
23 Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis. J Cyst Fibros 2008 0.85
24 Oxidative stress and cystic fibrosis-related diabetes: a pilot study in children. J Cyst Fibros 2008 0.83
25 Comparison of fingertip to arterial blood samples at rest and during exercise. Clin J Sport Med 2005 0.82
26 Whey protein hydrolysates decrease IL-8 secretion in lipopolysaccharide (LPS)-stimulated respiratory epithelial cells by affecting LPS binding to Toll-like receptor 4. Br J Nutr 2013 0.82
27 Evaluation of the impact of interferon-gamma release assays on the management of childhood tuberculosis. Pediatr Infect Dis J 2012 0.81
28 The evolution of exercise capacity and its limiting factors in cystic fibrosis. Paediatr Respir Rev 2012 0.81
29 Lung diffusion capacity for nitric oxide and carbon monoxide is impaired similarly following short-term graded exercise. Nitric Oxide 2004 0.81
30 Induced sputum in cystic fibrosis: within-week reproducibility of inflammatory markers. Clin Biochem 2004 0.80
31 Pressurized whey protein can limit bacterial burden and protein oxidation in Pseudomonas aeruginosa lung infection. Nutrition 2013 0.79
32 A contemporary evaluation of pulmonary function in children undergoing lung resection in infancy. J Pediatr Surg 2011 0.78
33 Lack of association of small-colony-variant Staphylococcus aureus strains with long-term use of azithromycin in patients with cystic fibrosis. J Clin Microbiol 2011 0.78
34 Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients? Pediatr Pulmonol 2010 0.78
35 ATS Consensus Statement: Research opportunities and challenges in pediatric pulmonology. Am J Respir Crit Care Med 2005 0.77
36 Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials. Contemp Clin Trials 2013 0.76
37 Effect of whey protein to modulate immune response in children with atopic asthma. Int J Food Sci Nutr 2006 0.75
38 Can I play? Pediatr Ann 2014 0.75
39 The cystic fibrosis effort in Canada: advancing on many fronts. Pediatr Pulmonol 2004 0.75
40 Inhaled corticosteroids or leukotriene receptor antagonists as first line therapy for asthma: aspects to consider in the light of the pro-con debate. Paediatr Respir Rev 2011 0.75
41 Authors' Reply. Respiration 2016 0.75
42 Isokinetic muscle function in COPD. Chest 2002 0.75
43 Measurement of lactate in whole human blood with near-infrared transmission spectroscopy. Talanta 2003 0.75